Modeling Cancer-Associated Mutations of PTEN in Mice

Antonella Papa1, Pier Paolo Pandolfi2

  • 1Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, 3800, Australia. antonella.papa@monash.edu.

Insights

This study details essential molecular techniques for creating genetically engineered mouse models (GEMMs). Researchers can use these methods for well-characterized animal models, including those with cancer-associated PTEN mutations.

Area of Science:

  • Genetics and Genomics
  • Mammalian Genetics
  • Molecular Biology

Background:

  • Genetically engineered mouse models (GEMMs) are crucial for biological research.
  • Existing gene-targeting strategies require robust molecular validation.
  • Controlled and well-characterized animal models are essential for reproducible scientific outcomes.

Purpose of the Study:

  • To provide detailed technical protocols for key molecular steps in generating GEMMs.
  • To outline methods for handling mouse embryonic stem cells.
  • To facilitate the creation of novel mouse models with specific genetic alterations, such as PTEN mutations.

Main Methods:

  • Mouse embryonic stem (ES) cell culture and maintenance.
  • Genomic DNA analysis using Southern Blotting.
  • Polymerase Chain Reaction (PCR) and sequencing for verifying DNA recombination.

Main Results:

  • Established protocols for critical molecular procedures in GEMM generation.
  • Demonstrated application of these methods for creating mouse models with cancer-associated PTEN mutations.
  • Provided a framework for quality control in the generation of genetically modified mice.

Conclusions:

  • The described molecular techniques are vital for the successful generation of well-characterized GEMMs.
  • These methods ensure the accuracy and reliability of genetic modifications in mouse models.
  • This work supports the advancement of research utilizing GEMMs, particularly in cancer biology.